US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRO Concept

1,677.91

-11.8744-0.70%

Number of Gainers:- -

Number of Losers:2

Number of Flat:1

PE:- -

High:1,700.36

Open:1,689.10

Low:1,645.47

Close:1,689.78

Loading ...

IQVIA Holdings Inc. Officer Eric Sherbet Reports Disposal of Common Shares

Biogen receives positive CHMP opinion for ZURZUVAE in PPD

ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression

Charles River Laboratories Shares up 7.6% After Larger Rival West Pharmaceutical Raises Annual Profit Forecast

THOMSON REUTERS

IQVIA Holdings Inc : Argus Research Raises Target Price to $230 From $180

THOMSON REUTERS

Evercore ISI Remains a Buy on IQVIA Holdings (IQV)

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

Sector Update: Health Care Stocks Rise Tuesday Afternoon

MT Newswires Live

Iqvia rises 16.3%

Iqvia Shares Climb After Tightening of 2025 Guidance Ranges

Charles River Laboratories and Elly's Team Secure FDA Approval for Pioneering Gene Therapy Targeting Rare Neurodevelopmental Disorder

Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

At US$159, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List?

Simply Wall St.

FDA Lifts Veil on Drug Approval Process: Four Chinese Pharma Rejections Expose Overseas Expansion Challenges

Charles River Laboratories International Inc. Announces Second-Quarter 2025 Financial Results Release

Morning Movers: Capricor Therapeutics plunges following CRL from FDA

Video: Capricor plunges after CRL, Performance Foods up after seeing interest

Capricor Receives FDA CRL for Deramiocel BLA

Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4530/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"CRO Concept","latestPrice":1677.9094,"timestamp":1753473599999,"preClose":1689.7838,"halted":0,"volume":2879267,"delay":0,"changeRate":-0.007027,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-11.87439,"latestTime":"07-25 16:00:00 EDT","open":1689.101,"high":1700.3616,"low":1645.4725,"amount":553846634.713345,"amplitude":0.032483,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.59967,"peRate":33.901524,"turnoverRate":0.013701,"increases":0,"decrements":2,"flats":0,"marketCap":42548942848,"floatMarketCap":40777664512},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":1700.3616,"amplitude":0.032483,"preClose":1689.7838,"low":1645.4725,"pbRate":"4.59967","latestPrice":1677.9094,"volume":2879267,"delay":0,"open":1689.101,"prevYearClose":1673.3123,"prevWeekClose":1374.9569,"prevMonthClose":1348.1335,"prevQuarterClose":1348.1335,"fiveDayClose":1374.9569,"twentyDayClose":1351.209,"sixtyDayClose":1255.8733,"secType":"PLATE","market":"US","turnoverRate":0.013701,"peRate":33.901524,"marketCap":42548942848,"floatMarketCap":40777664512,"timestamp":1753473599999,"nameCN":"CRO Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":0,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554792521","title":"IQVIA Holdings Inc. Officer Eric Sherbet Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2554792521","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554792521?lang=en_us&edition=fundamental","pubTime":"2025-07-26 05:01","pubTimestamp":1753477296,"startTime":"0","endTime":"0","summary":"Eric Sherbet, an officer at IQVIA Holdings Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IQVIA Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL6Jsnx7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710400.SGD","LU1989764664.SGD","BK4585","LU1201861165.SGD","LU0648000940.SGD","LU0130103400.USD","LU0648001328.SGD","LU0980610538.SGD","LU0130518102.USD","BK4588","LU0882574055.USD","LU0477156953.USD","BK4530","LU1261432733.SGD","LU0198837287.USD","LU1791710582.SGD","IQV","LU1989764748.USD","LU0130517989.USD","LU0477156797.USD","LU1201861249.SGD","LU0528227936.USD","LU0130102774.USD","BK4121"],"gpt_icon":0},{"id":"2554764498","title":"Biogen receives positive CHMP opinion for ZURZUVAE in PPD","url":"https://stock-news.laohu8.com/highlight/detail?id=2554764498","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554764498?lang=en_us&edition=fundamental","pubTime":"2025-07-25 19:31","pubTimestamp":1753443100,"startTime":"0","endTime":"0","summary":"Biogen (BIIB) announced the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-receives-positive-chmp-opinion-for-zurzuvae-in-ppd-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-receives-positive-chmp-opinion-for-zurzuvae-in-ppd-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4121","BK4561","IE00B19Z9Z06.USD","BIIB","IE00B19Z9P08.USD","CHMP","BK4139","BK4585","LU0320765992.SGD","LU0234570918.USD","LU0889565916.HKD","BK4532","BK4588","IE00B894F039.SGD","BK4533","BK4530","BK4087","PPD"],"gpt_icon":0},{"id":"2554764671","title":"ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2554764671","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554764671?lang=en_us&edition=fundamental","pubTime":"2025-07-25 19:20","pubTimestamp":1753442400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., July  25, 2025  (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a po","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/25/3121730/0/en/ZURZUVAE-zuranolone-Receives-Positive-Opinion-from-CHMP-for-the-Treatment-of-Women-with-Postpartum-Depression.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","PAM","PPD","BK4201","BK4121","EMA","BK4561","DEA","EC","CHMP","BK4563","BK4194","BK4081","BK4223","BK4530"],"gpt_icon":0},{"id":"2553878680","title":"Charles River Laboratories Shares up 7.6% After Larger Rival West Pharmaceutical Raises Annual Profit Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2553878680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553878680?lang=en_us&edition=fundamental","pubTime":"2025-07-24 21:52","pubTimestamp":1753365162,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nL4N3TL1OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B64QTZ34.USD","LU0757428866.USD","IE00BFXG0V08.USD","BK4567","BK4588","CRL","BK4504","WST","LU0390134368.USD","BK4121","BK4530","BK4585","LU1815336091.USD","IE00BYQQ9H92.USD"],"gpt_icon":0},{"id":"2553022142","title":"IQVIA Holdings Inc : Argus Research Raises Target Price to $230 From $180","url":"https://stock-news.laohu8.com/highlight/detail?id=2553022142","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553022142?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:25","pubTimestamp":1753356349,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL211:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0980610538.SGD","LU1791710582.SGD","BK4121","LU1989764748.USD","LU1261432733.SGD","LU0477156797.USD","LU0130518102.USD","LU0648001328.SGD","LU1201861249.SGD","BK4585","LU0882574055.USD","BK4588","LU0477156953.USD","LU1791710400.SGD","LU1201861165.SGD","LU0648000940.SGD","LU1989764664.SGD","LU0130102774.USD","IQV","BK4530","LU0198837287.USD","LU0130517989.USD","LU0130103400.USD","LU0528227936.USD"],"gpt_icon":0},{"id":"2553353261","title":"Evercore ISI Remains a Buy on IQVIA Holdings (IQV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2553353261","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553353261?lang=en_us&edition=fundamental","pubTime":"2025-07-23 07:25","pubTimestamp":1753226722,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on IQVIA Holdings today and set a price target of $220.00. The company’s shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-remains-a-buy-on-iqvia-holdings-iqv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-remains-a-buy-on-iqvia-holdings-iqv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1791710400.SGD","LU1791710582.SGD","BK4588","BK4585","LU0130102774.USD","LU1201861165.SGD","LU0882574055.USD","BK4121","LU1989764664.SGD","LU0648000940.SGD","LU1261432733.SGD","LU0980610538.SGD","LU1201861249.SGD","LU0130103400.USD","LU0477156953.USD","LU1989764748.USD","LU0648001328.SGD","BK4530","LU0130517989.USD","IQV","CFA","LU0130518102.USD","LU0198837287.USD","LU0477156797.USD","LU0528227936.USD"],"gpt_icon":0},{"id":"2553326387","title":"BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2553326387","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553326387?lang=en_us&edition=fundamental","pubTime":"2025-07-23 03:30","pubTimestamp":1753212608,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDTS&P 500 .SPXTop PerformersPercent ChangeIQVIA Holdings Inc IQV.N+18.9%DR Horton Inc DHI.N+16.3%Pultegroup Inc PHM.N+11.6%Northrop Grumman Corp NOC.N+9.7%Charles River Laboratories International Inc CRL.N+9.4%Bottom PerformersPercent ChangeLockheed Martin Corp LMT.N-9.6%Philip Morris International Inc PM.N-8.1%Equifax Inc EFX.N-8.0%MSCI Inc MSCI.N-7.8%General Motors Co GM.N-7.8%As of 03:30 p.m., the S&P 500 .SPX gained 7.18 points, or 0.11%, to 6,312.78 and had posted 20 new 52-week highs and one new low.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nL8N3TJ1XW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0198837287.USD","LU0528227936.USD","LU0942090050.USD","LU1244550577.SGD","LU0980610538.SGD","LU0072461881.USD","LU0648001328.SGD","LU1815336091.USD","EFX","IQV","PHM","GB00B4LPDJ14.GBP","LU1261432733.SGD","LU0320765489.SGD","LU0345770993.USD","GM","LU1988902786.USD","LU1929549753.HKD","LU1066051811.HKD","LMT","LU0070302665.USD","LU0477156953.USD","NOC","LU1066053197.SGD","BK4516","LU0289960550.SGD","LU0006061336.USD","LU0868494708.USD","PM","MSCI","LU1791710582.SGD","LU0314106906.USD","LU0708995401.HKD","BK4561","LU0109391861.USD","LU0882574055.USD","LU0661504455.SGD","DHI","LU1064131342.USD","LU2210149790.SGD","LU1989764748.USD","CRL","LU2095319765.USD","LU1201861249.SGD","BK4530","LU1496350502.SGD","LU2404859741.USD","LU0130517989.USD","GB00B4QBRK32.GBP","BK4533"],"gpt_icon":1},{"id":"2553250149","title":"Sector Update: Health Care Stocks Rise Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2553250149","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553250149?lang=en_us&edition=fundamental","pubTime":"2025-07-23 01:54","pubTimestamp":1753206869,"startTime":"0","endTime":"0","summary":"Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each advancing about 1.5%.The iShares Biotechnology ETF  climbed 2.4%.In corporate news, AstraZeneca  shares rose 2.3% after the company said it plans to invest $50 billion in the US by 2030, including a new manufacturing facility in Virginia.IQVIA  shares jumped 18% after it reported higher Q2 adjusted earnings and revenue.Sanofi  added 1.4% after the drugmaker said Beyfortus for respiratory syncytial virus prevention in infants met both of its primary endpoints in its largest US real-world study.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0130103400.USD","LU2456880835.USD","LU0198837287.USD","LU1791710400.SGD","LU2462157665.USD","LU0882574055.USD","LU0980610538.SGD","LU1989764664.SGD","LU0477156797.USD","LU1201861165.SGD","LU1261432733.SGD","BK4585","LU1829250122.USD","LU1989764748.USD","LU0648000940.SGD","IBB","BK4530","LU0130518102.USD","LU1791710582.SGD","BK4121","LU0648001328.SGD","IQV","BK4568","LU0320765992.SGD","IE00BFXG1179.USD","SNY","LU0130102774.USD","LU1201861249.SGD","LU2417539215.USD","BK4007","BK4588","LU0528227936.USD","LU0889565916.HKD","XLV","LU2236285917.USD","LU0477156953.USD","AZN","BK4581","LU0109394709.USD","LU0130517989.USD"],"gpt_icon":0},{"id":"2553251213","title":"Iqvia rises 16.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553251213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553251213?lang=en_us&edition=fundamental","pubTime":"2025-07-22 22:05","pubTimestamp":1753193140,"startTime":"0","endTime":"0","summary":"Iqvia (IQV) is up 16.3%, or $25.89 to $184.85. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/iqvia-rises-16-3-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/iqvia-rises-16-3-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0648001328.SGD","IQV","LU0198837287.USD","LU0528227936.USD","LU1201861165.SGD","BK4585","LU1791710582.SGD","LU1791710400.SGD","LU0882574055.USD","LU0980610538.SGD","LU0477156953.USD","LU0130102774.USD","LU0130103400.USD","BK4121","LU1989764664.SGD","LU0130517989.USD","LU1261432733.SGD","LU0130518102.USD","BK4530","LU0648000940.SGD","LU1989764748.USD","BK4588","LU1201861249.SGD","LU0477156797.USD"],"gpt_icon":0},{"id":"2553525644","title":"Iqvia Shares Climb After Tightening of 2025 Guidance Ranges","url":"https://stock-news.laohu8.com/highlight/detail?id=2553525644","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553525644?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:30","pubTimestamp":1753187400,"startTime":"0","endTime":"0","summary":"Shares of Iqvia rallied premarket after the provider of healthcare technology and research services tightened the range for its annual earnings and revenue forecasts.The Durham, N.C., firm, which conducts clinical trials for drug companies, among other services, on Tuesday posted earnings of $266 million, or $1.54 a share, down from $363 million, or $1.97 a share. Adjusted earnings came to $2.81 per share, topping the average Wall Street estimate of $2.77.Revenue rose 5.3% to $4.02 billion, topping the average analyst forecast of $3.96 billion, according to FactSet. Research-and-development revenue ticked up 2.5% to $2.2 billion. The backlog at its research-and-development unit also rose 5.1% to $32.1 billion, and the company expects $8.1 billion of that to be recognized as revenue in the next 12 months.Iqvia forecast 2025 adjusted earnings in a range between $11.75 and $12.05 a share, compared with a previous estimate between $11.70 and $12.10 a share, and in line with the Wall Street","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Iqvia Shares Climb After Tightening of 2025 Guidance Ranges","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710400.SGD","LU0648001328.SGD","LU0130102774.USD","LU1791710582.SGD","LU1989764748.USD","LU0528227936.USD","LU1201861165.SGD","LU1261432733.SGD","LU0477156953.USD","LU0882574055.USD","BK4588","BK4121","IQV","LU0130517989.USD","LU0477156797.USD","LU0130103400.USD","LU0648000940.SGD","BK4530","LU1989764664.SGD","BK4585","LU0980610538.SGD","LU0130518102.USD","LU1201861249.SGD","LU0198837287.USD"],"gpt_icon":0},{"id":"2553825311","title":"Charles River Laboratories and Elly's Team Secure FDA Approval for Pioneering Gene Therapy Targeting Rare Neurodevelopmental Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2553825311","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553825311?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:00","pubTimestamp":1753185649,"startTime":"0","endTime":"0","summary":"Charles River Laboratories and Elly's Team Secure FDA Approval for Pioneering Gene Therapy Targeting Rare Neurodevelopmental Disorder. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via Business Wire  on July 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDLbfZPtR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","LU0757428866.USD","CRL","BK4588","BK4530","BK4121","BK4585","LU1815336091.USD"],"gpt_icon":0},{"id":"2553230212","title":"Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2553230212","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553230212?lang=en_us&edition=fundamental","pubTime":"2025-07-22 19:00","pubTimestamp":1753182000,"startTime":"0","endTime":"0","summary":"WOBURN, Mass., July  22, 2025  (GLOBE NEWSWIRE) -- Replimune Group, Inc.(NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today anno","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"994914146069ed98a1b9497b1d747f21","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/22/3119299/0/en/Replimune-Receives-Complete-Response-Letter-from-FDA-for-RP1-Biologics-License-Application-for-the-Treatment-of-Advanced-Melanoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0031619046.USD","IE00B7SZL793.SGD","LU0757428866.USD","BK4585","BK4121","CRL","LU0390134368.USD","AEIS","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4588","REPL","BK4157","BK4530","LU1815336091.USD"],"gpt_icon":0},{"id":"2552543573","title":"At US$159, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List?","url":"https://stock-news.laohu8.com/highlight/detail?id=2552543573","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552543573?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:42","pubTimestamp":1752752578,"startTime":"0","endTime":"0","summary":"IQVIA Holdings Inc. ( NYSE:IQV ) saw a double-digit share price rise of over 10% in the past couple of months on the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/at-us159-is-it-time-to-put-iqvia-holdings-inc-nyseiqv-on-you","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1791710400.SGD","LU0648001328.SGD","NYSE","LU0130102774.USD","LU1791710582.SGD","LU1989764748.USD","LU0528227936.USD","LU1201861165.SGD","LU1261432733.SGD","LU0477156953.USD","LU0882574055.USD","BK4588","BK4121","IQV","LU0130517989.USD","LU0477156797.USD","LU0130103400.USD","LU0648000940.SGD","BK4530","LU1989764664.SGD","BK4585","LU0980610538.SGD","LU0130518102.USD","LU1201861249.SGD","LU0198837287.USD"],"gpt_icon":0},{"id":"1130979950","title":"FDA Lifts Veil on Drug Approval Process: Four Chinese Pharma Rejections Expose Overseas Expansion Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=1130979950","media":"Market Watcher","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130979950?lang=en_us&edition=fundamental","pubTime":"2025-07-16 10:33","pubTimestamp":1752633211,"startTime":"0","endTime":"0","summary":"In an unprecedented transparency move, the U.S. FDA has publicly released 202 Complete Response Letters (CRLs) – essentially rejection notices – exposing the stumbles of global pharmaceutical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK1161","LU0348783233.USD","IE00B543WZ88.USD","BK4585","BK4530","LU1815336091.USD","09926","LU1720050803.USD","LU0390134368.USD","BK4588","LU0757428866.USD","LU1794554557.SGD","LU0417516571.SGD","BK1574","CRL","IE00BPRC5H50.USD","LU2488822045.USD","IE00B5MMRT66.SGD","LU0348784397.USD"],"gpt_icon":0},{"id":"2551516449","title":"Charles River Laboratories International Inc. Announces Second-Quarter 2025 Financial Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2551516449","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551516449?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:01","pubTimestamp":1752580878,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International Inc. will release its second-quarter 2025 financial results on August 6th, before the market opens. A conference call to discuss these results is scheduled for the same day at 9:00 a.m. ET. Investors can listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via Business Wire  on July 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL8Djf9x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","LU0390134368.USD","LU1815336091.USD","BK4121","BK4585","BK4588","LU0757428866.USD","CRL"],"gpt_icon":0},{"id":"2550956134","title":"Morning Movers: Capricor Therapeutics plunges following CRL from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2550956134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550956134?lang=en_us&edition=fundamental","pubTime":"2025-07-11 21:00","pubTimestamp":1752238836,"startTime":"0","endTime":"0","summary":"U.S. stock futures edged lower as President Trump escalated trade tensions, announcing a hike in tariffs on Canadian imports, effective August 1, p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/morning-movers-capricor-therapeutics-plunges-following-crl-from-fda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/morning-movers-capricor-therapeutics-plunges-following-crl-from-fda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0757428866.USD","LU0390134368.USD","CAPR","BK4585","BK4588","BK4530","CRL","LU1815336091.USD","BK4139","BK4121"],"gpt_icon":0},{"id":"2550150956","title":"Video: Capricor plunges after CRL, Performance Foods up after seeing interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2550150956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550150956?lang=en_us&edition=fundamental","pubTime":"2025-07-11 20:56","pubTimestamp":1752238562,"startTime":"0","endTime":"0","summary":"The Fly has brought its to-the-moment stock market reporting to YouTube! Subscribe if you want to know how the markets will open, which stocks will...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/video-capricor-plunges-after-crl-performance-foods-up-after-seeing-interest-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/video-capricor-plunges-after-crl-performance-foods-up-after-seeing-interest-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PFGC","SG9999014013.SGD","CRL","SG9999014039.USD","LU0757428866.USD","SG9999014021.USD","BK4530","BK4121","BK4585","LU0390134368.USD","BK4588","LU1815336091.USD","SG9999014005.SGD","BK4102"],"gpt_icon":0},{"id":"2550930337","title":"Capricor Receives FDA CRL for Deramiocel BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2550930337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550930337?lang=en_us&edition=fundamental","pubTime":"2025-07-11 18:57","pubTimestamp":1752231456,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics ( ($CAPR) ) has shared an announcement. On July 11, 2025, Capricor Therapeutics announced it received a Complete Response Let...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/capricor-receives-fda-crl-for-deramiocel-bla?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/capricor-receives-fda-crl-for-deramiocel-bla?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRL","LU0757428866.USD","BK4530","BK4121","LU0390134368.USD","BK4588","LU1815336091.USD","BK4585"],"gpt_icon":0},{"id":"2550343569","title":"Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2550343569","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550343569?lang=en_us&edition=fundamental","pubTime":"2025-07-11 18:00","pubTimestamp":1752228000,"startTime":"0","endTime":"0","summary":"New PDUFA Action Date of December 13, 2025 $75 Million Royalty Purchase AgreementPayment from RTW Extended Through 2025 MONTREAL and CHARLOTTE, N.C., July  11, 2025  (GLOBE NEWSWIRE) -- Milestone Phar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/11/3113902/0/en/Milestone-Pharmaceuticals-Announces-FDA-Acceptance-of-the-Company-s-Response-to-the-CRL-for-CARDAMYST-etripamil-Nasal-Spray.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","BK4530","BK4588","BK4121","LU0757428866.USD","CRL","BK4585","LU1815336091.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}